Increased bone turnover in patients with hypercholesterolemia

Endocrine Journal

Volumn 55, Issue 1, 2008, Pages 143-151

  Majima, Takafumi ^a,b,c,e   Shimatsu, Akira ^a   Komatsu, Yasato ^b   Satoh, Noriko ^a   Fukao, Atsushi ^d   Ninomiya, Kiyoshi ^c   Matsumura, Tadashi ^c   Nakao, Kazuwa ^b  

^a NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c RAKUWAKAI OTOWA HOSPITAL   (Japan)

^d AINO UNIVERSITY   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

Bone turnover; Dyslipidemia; Hypercholesterolemia; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTERIOSCLEROSIS; ARTICLE; BONE ATROPHY; BONE METABOLISM; BONE TURNOVER; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DYSLIPIDEMIA; FEMALE; FRAGILITY FRACTURE; HUMAN; HYPERCHOLESTEROLEMIA; JAPANESE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEX RATIO; ADOLESCENT; AGE DISTRIBUTION; AGED; BLOOD; BODY MASS; BONE; BONE REMODELING; CASE CONTROL STUDY; COMPARATIVE STUDY; MENOPAUSE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SEXUAL DEVELOPMENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BODY MASS INDEX; BONE AND BONES; BONE REMODELING; CASE-CONTROL STUDIES; COLLAGEN TYPE I; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MENOPAUSE; MIDDLE AGED; OSTEOPOROSIS; PEPTIDES; SEX CHARACTERISTICS;

EID: 42049115142     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K07E-004     Document Type: Article

References (39)

1. Tanko LB, Bagger YZ, Christiansen C (2003) Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women. Calcif Tissue Int 73: 15-20.
2. Pennisi P, Signorelli SS, Riccobene S, Celotta G, Di Pino L, La Malfa T, Fiore CE (2004) Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos Int 15: 389-395.
3. Trivedi DP, Khaw KT (2001) Bone mineral density at the hip predicts mortality in elderly men. Osteoporos Int 12: 259-265.
4. Samelson EJ, Kiel DP, Broe KE, Zhang Y, Cupples LA, Hannan MT, Wilson PW, Levy D, Williams SA, Vaccarino V (2004) Metacarpal cortical area and risk of coronary heart disease: the Framingham Study. Am J Epidemiol 159: 589-595.
5. Koshiyama H, Wada Y, Nakamura Y (2001) Hypercholesterolemia as a possible risk factor for osteopenia in type 2 diabetes mellitus. Arch Intern Med 161: 1678.
6. Yamaguchi T, Sugimoto T, Yano S, Yamauchi M, Sowa H, Chen Q, Chihara K (2002) Plasma lipids and osteoporosis in postmenopausal women. Endocr J 49: 211-217.
7. Wu LY, Yang TC, Kuo SW, Hsiao CF, Hung YJ, Hsieh CH, Tseng HC, Hsieh AT, Chen TW, Chang JB, Pei D (2003) Correlation between bone mineral density and plasma lipids in Taiwan. Endocr Res 29: 317-325.
8. Tanko LB, Bagger YZ, Nielsen SB, Christiansen C (2003) Does serum cholesterol contribute to vertebral bone loss in postmenopausal women? Bone 32: 8-14.
9. Orozco P (2004) Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women. Eur J Epidemiol 19: 1105-1112.
10. Cui LH, Shin MH, Chung EK, Lee YH, Kweon SS, Park KS, Choi JS (2005) Association between bone mineral densities and serum lipid profiles of pre- and postmenopausal rural women in South Korea. Osteoporos Int 16: 1975-1981.
11. Adami S, Braga V, Zamboni M, Gatti D, Rossini M, Bakri J, Battaglia E (2004) Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcif Tissue Int 74: 136-142.
12. Samelson EJ, Cupples LA, Hannan MT, Wilson PW, Williams SA, Vaccarino V, Zhang Y, Kiel DP (2004) Long-term effects of serum cholesterol on bone mineral density in women and men: the Framingham Osteoporosis Study. Bone 34: 557-561.
13. Solomon DH, Avorn J, Canning CF, Wang PS (2005) Lipid levels and bone mineral density. Am J Med 118: 1414.
14. Parhami F, Jackson SM, Tintut Y, Le V, Balucan JP, Territo M, Demer LL (1999) Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 14: 2067-2078.
15. Tintut Y, Parhami F, Tsingotjidou A, Tetradis S, Territo M, Demer LL (2002) 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem 277: 14221-14226.
16. Cummings SR, Bauer DC (2000) Do statins prevent both cardiovascular disease and fracture? JAMA 283: 3255-3257.
17. Parhami F, Mody N, Gharavi N, Ballard AJ, Tintut Y, Demer LL (2002) Role of the cholesterol biosynthetic pathway in osteoblastic differentiation of marrow stromal cells. J Bone Miner Res 17: 1997-2003.
18. Koay MA, Woon PY, Zhang Y, Miles LJ, Duncan EL, Ralston SH, Compston JE, Cooper C, Keen R, Langdahl BL, MacLelland A, O'Riordan J, Pols HA, Reid DM, Uitterlinden AG, Wass JA, Brown MA (2004) Influence of LRP5 polymorphisms on normal variation in BMD. J Bone Miner Res 19: 1619-1627.
19. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML; Osteoporosis-Pseudoglioma Syndrome Collaborative Group (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513-523.
20. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA 2nd, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L (2002) Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157: 303-314.
21. Kokubu C, Heinzmann U, Kokubu T, Sakai N, Kubota T, Kawai M, Wahl MB, Galceran J, Grosschedl R, Ozono K, Imai K (2004) Skeletal defects in ringelschwanz mutant mice reveal that Lrp6 is required for proper somitogenesis and osteogenesis. Development 131: 5469-5480.
22. Mani A, Radhakrishnan J, Wang H, Mani A, Mani MA, Nelson-Williams C, Carew KS, Mane S, Najmabadi H, Wu D, Lifton RP (2007) LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315: 1278-1282.
23. Gerdes LU, Vestergaard P, Hermann AP, Mosekilde L (2001) Regional and hormone-dependent effects of apolipoprotein E genotype on changes in bone mineral in perimenopausal women. J Bone Miner Res 16: 1906-1916.
24. Tintut Y, Morony S, Demer LL (2004) Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Vasc Biol 4: e6-10.
25. Parhami F, Tintut Y, Beamer WG, Gharavi N, Goodman W, Demer LL (2001) Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res 16: 182-188.
26. Bauer DC (2003) HMG CoA reductase inhibitors and the skeletal: A comprehensive review. Osteoporos Int 14: 273-282.
27. Majima T, Komatsu Y, Yamada T, Koike Y, Shigemoto M, Takagi C, Hatanaka I, Nakao K. (2005) Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients. Osteoporos Int 16: 907-913.
28. Majima T, Komatsu Y, Fukao A, Ninomiya K, Matsumura T, Nakao K (2007) Short-term Effects of Atorvastatin on Bone Turnover in Male Patients with Hypercholesterolemia. Endocr J 54: 145-151.
29. Shilbayeh S (2003) Prevalence of osteoporosis and its reproductive risk factors among Jordanian women: a cross-sectional study. Osteoporos Int 14: 929-940.
30. Brownbill RA, Ilich JZ (2006) Lipid profile and bone paradox: higher serum lipids are associated with higher bone mineral density in postmenopausal women. J Womens Health (Larchmt) 15: 261-270.
31. Mundy G, Garrett R, Harris S, et al. (1999) Stimulation of bone formation in vitro and in rodents by statins. Science 286: 1946-1949.
32. Watanabe S, Fukumoto S, Takeuchi Y, Fujita H, Nakano T, Fujita T (2001) Effects of 1-year treatment with fluvastatin or pravastatin on bone. Am J Med 110: 584-587.
33. Rejnmark L, Olsen ML, Johnsen SP, Vestergaard P, Sorensen HT, Mosekilde L (2004) Hip fracture risk in statin users - a population-based Danish case-control study. Osteoporos Int 15: 452-458.
34. Bjarnason NH, Riis BJ, Christiansen C (2001) The effect of fluvastatin on parameters of bone remodeling. Osteoporos Int 12: 380-384.
35. Rejnmark L, Buus NH, Vestergaard P, Andreasen F, Larsen ML, Mosekilde L (2002) Statins decrease bone turnover in postmenopausal women: A cross-sectional study. Eur J Clin Invest 32: 581-589.
36. Kuzuya M, Suzuki Y, Asai T, Koike T, Kanda S, Nakamura A, Satake S, Umegaki H, Iguchi A (2003) Atorvastatin, 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces bone resorption in the elderly. J Am Geriatr Soc 51: 1677-1678.
37. Berthold HK, Unverdorben S, Zittermann A, Degenhardt R, Baumeister B, Unverdorben M, Krone W, Vetter H, Gouni-Berthold I (2004) Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women. Osteoporos Int 15: 459-467.
38. Rosenson RS, Tangney CC, Langman CB, Parker TS, Levine DM, Gordon BR (2005) Short-term reductioidin bone markers with high-dose simvastatin. Osteoporos Int 16: 1272-1276.
39. Garnero P, Dargent-Molina P, Hans D, Schott AM, Breart G, Meunier PJ, Delmas PD (1998) Do markers of bone resorption add to bone mineral density and ultrasonographic heel measurement for the prediction of hip fracture in elderly women? The EPIDOS prospective study. Osteoporos Int 8: 563-569.